Madryn Health Partners, LP's Form 4 filing
Venus Concept Inc. (VERO) · filed Apr 2, 2025
- Accession no.
- 0000950170-25-049649
- Filed
- Apr 2, 2025, 5:47 PM ET
- Trade date
- Mar 31, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Madryn Health Partners, LPCIK 0001650490 | 10% Owner |
| Madryn Asset Management, LPCIK 0001787423 | 10% Owner |
| Madryn Health Advisors, LPCIK 0001836559 | 10% Owner |
| Madryn Health Partners (Cayman Master), LPCIK 0001836788 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common Stock | PPurchaseAcquired | +64,454 | –F2 | – | – | Indirect | |
| Mar 31, 2025 | Common Stock | DReturned to the companyDisposed | −106,121 | –F2 | – | – | Indirect | |
| Mar 31, 2025 | Common Stock | PPurchaseAcquired | +3,448,279 | –F2 | – | 1,159,880 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The reported transactions involved an exchange of existing secured subordinated convertible notes in the aggregate principal amount of $28,015,827.33 (the "Existing Notes") for (i) new secured subordinated convertible notes in the aggregate principal amount of $17,015,808.33 (the "New Notes") and (ii) 379,311 shares of Series Y Convertible Preferred Stock (the "Series Y Preferred Stock").
Referenced by the price of 3 transactions in Table II.